News

Urinary tract infections (UTIs) in children often go unnoticed due to vague or age-specific symptoms. However, timely ...
US-based biotechnology company Arcutis Biotherapeutics has enrolled the first child in an open-label Phase II trial of Zoryve ...
An analysis of a small number of patients suggests that gut microbiome alterations may contribute to HS in both adults and ...